Zurueck zur Suche

Reporte zur Charge U038863

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TN 6 NH 2 ME 1 MI 1

VAERS 2608772

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038863

mild
Staat
TN
Alter
-
Geschlecht
F
Eingang
04.04.2023
Impfdatum
14.10.2022
Beginn
14.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Urticaria

Symptomtext

Urticaria; Injection site erythema; This case was retrieve during the Reporting System monitoring on 12-JAN-2023. The original narrative from the sender is the following: Mother reports that approximately 3 hours after vaccination she noticed severe redness on entire right thigh and several hives on infant's abdomen. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "Urticaria", and "Injection site erythema". No further information is expected

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
VITAMIN D SUPPORT
Allergien
-
Vorherige Impfungen
-

VAERS 2544201

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038863

mild
Staat
NH
Alter
-
Geschlecht
F
Eingang
28.12.2022
Impfdatum
17.08.2022
Beginn
18.08.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Crying Diarrhoea Vomiting

Symptomtext

loose watery stools; Inconsolable crying; Emesis; This case was retrieved during the Reporting System monitoring on 12-OCT-2022 with the following Primary ID 2417741-1. The original narrative from the sender is the following: The day after the vaccines were administered, the infant developed loose watery stools, followed by inconsolable crying and emesis. Parents brought child to the ER, where she was able to eat after taking ondansetron PO and was discharged home. Baby was seen in the office today and appeared happy with a normal abdominal exam. Passed a normal BM today. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "Diarrhoea" "Crying" and "Vomiting". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
COVID-19 ((Baby tested positive on 30-Jul-2022))
Vorgeschichte
-
Andere Medikamente
VITAMIN D NOS
Allergien
-
Vorherige Impfungen
-

VAERS 2488419

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038863

mild
Staat
-
Alter
-
Geschlecht
M
Eingang
25.10.2022
Impfdatum
04.10.2022
Beginn
11.10.2022
Tage bis Beginn
7,0
Dosis
1
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Diarrhoea Pyrexia Rotavirus test positive Stool analysis

Symptomtext

multiple watery diarrheal stools per day, low grade fever X 10 days (still ongoing)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
Stool pathogen PCR 10/18/2022 + Rotavirus
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2481783

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038863

mild
Staat
TN
Alter
0,2
Geschlecht
F
Eingang
18.10.2022
Impfdatum
14.10.2022
Beginn
14.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Urticaria

Symptomtext

Mother reports that approximately 3 hours after vaccination she noticed severe redness on entire right thigh and several hives on infant's abdomen.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Vitamin D supplement
Allergien
no know allergies
Vorherige Impfungen
-

VAERS 2420037

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038863

mild
Staat
ME
Alter
0,3
Geschlecht
F
Eingang
25.08.2022
Impfdatum
10.08.2022
Beginn
14.08.2022
Tage bis Beginn
4,0
Dosis
2
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Rash Rash erythematous Urticaria

Symptomtext

Red welts on face about the size of a pencil eraser.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2417741

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038863

mild
Staat
NH
Alter
0,3
Geschlecht
F
Eingang
22.08.2022
Impfdatum
17.08.2022
Beginn
18.08.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Crying Diarrhoea Vomiting

Symptomtext

The day after the vaccines were administered, the infant developed loose watery stools, followed by inconsolable crying and emesis. Parents brought child to the ER, where she was able to eat after taking ondansetron PO and was discharged home. Baby was seen in the office today and appeared happy with a normal abdominal exam. Passed a normal BM today.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Covid (baby tested positive on 7/30/2022)
Vorgeschichte
None
Andere Medikamente
Vitamin D 400 IU PO daily
Allergien
None
Vorherige Impfungen
-

VAERS 2643056

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038863

gering
Staat
TN
Alter
-
Geschlecht
M
Eingang
08.06.2023
Impfdatum
30.05.2023
Beginn
30.05.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Confirmed that no symptomatic adverse events were reported/No additional AE; Administration of ROTATEQ that was expired to two patients; This spontaneous report was received from an office manager referring to a 4-months-old male patient. The patient's pertinent medical history, concomitant medications, and drug reactions or allergies were not reported. On 30-MAY-2023, the patient received the first dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) vial 2 mL, once, orally, lot number: U038863 was verified to be a valid lot number for Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), expiration date was provided and upon internal validation was confirmed to be: 27-MAY-2023 (expired product administered) administered as prophylaxis. It was confirmed that no symptomatic adverse events were reported (No adverse event). Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) did not have any previous temperature excursion outside recommended range in the past. This is one of two reports received from the same reporter.; Sender's Comments: US-009507513-2306USA000682:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2641170

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038863

gering
Staat
TN
Alter
2,0
Geschlecht
M
Eingang
05.06.2023
Impfdatum
31.05.2023
Beginn
31.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No symptomatic adverse event were reported; Inbound call from office manager calling to report administration of ROTATEQ that was expired to two patients.; This spontaneous report has been received from an office manager, regarding a 2-years-old male patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 31-MAY-2023, the patient was vaccinated with an expired dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) oral liquid, at a dose of 2 milliliters (ml) once as prophylaxis (lot number: U038863, which was determined to be valid, with an expiration date on 27-MAY-2023) (Expired product administered). The vaccine did not have any previous temperature excursion outside recommended range in the past. No additional adverse event was reported. This is one of two reports from the same reporter.; Sender's Comments: US-009507513-2306USA000729:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2639641

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge u038863

gering
Staat
TN
Alter
-
Geschlecht
U
Eingang
01.06.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

We gave the Vaccine that was out of date by 3 days

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2486836

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038863

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
24.10.2022
Impfdatum
03.10.2022
Beginn
03.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additonal AE's and no PQC's were reported; A medical assistant reported that an improperly stored dose of ROTATEQ pursuant to a temperature excursion was administered to a patient.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 03-OCT-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid (quantity 1, lot #U038863, expiration date: 27-MAY-2023) as directed to prevent rotavirus. The vaccine was exposed to temperature excursion of 9.1 degrees Celsius for 21 minutes. There was no previous temperature excursion. No additional AE's and no PQC's were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2427567

MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U038863

gering
Staat
TN
Alter
0,5
Geschlecht
M
Eingang
02.09.2022
Impfdatum
25.08.2022
Beginn
26.08.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
PO / MO
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Unevaluable event

Symptomtext

See attached ER visit note.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
See attached ER visit note
Aktuelle Erkrankungen
-
Vorgeschichte
Dx with seizures after 4 month vaccines
Andere Medikamente
Keppra, famotidine
Allergien
NKA
Vorherige Impfungen
Seizures after 4 month vaccines